IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in late-stage development with its DNA-mediated immunotherapy, announces that the Company will host a conference call at 11:00 a.m. EDT on Tuesday ...

Casgevy’s approval changed the sickle cell disease landscape. Developed by Vertex Pharmaceuticals and CRISPR Therapeutics, the therapy showed that the disease could be tackled at its genetic root, ...

With cutting-edge sports medicine and sci-fi gadgetry, more and more athletes are figuring out how to extend their careers.

UCB will pay up to $2.2bn for Candid Therapeutics, betting on cizutamig and the wider T-cell engager rush in autoimmune disease.

And that is a problem, because smell is extremely important not only for getting information about our surroundings, but also ...

Ahead of the election, the Southern California News Group compiled a list of questions to pose to the candidates vying to ...

A working research prototype designed to connect quantum systems from different vendors, in all major encoding modalities, at ...

Interested in trying out ear seeding for yourself? Read on to find out everything there is to know according to TCM experts.

Jennifer Brown moved to Humboldt County in 2017 and founded NeuroHealth in 2018. At the time, she worked in private practice as a Licensed Clinical Social Worker specializing in clients with trauma, ...

The Idaho-based joint venture with Saint Alphonsus Health System, which is part of Trinity Health, operates three ...

KELOWNA, BC / / May 5, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) ("Lexaria" or the "Company"), a global innovator in ...

An in-depth look some developments that may have flown under the radar at NAB 2026, from the rise of differentiated agentic media solutions and workflows and the demise of SaaS to advances in audio ...